Summary
Elevance Health, Inc. (then Anthem, Inc.) filed an 8-K on March 16, 2016, primarily to reaffirm its financial guidance for the full year 2016. The company communicated to securities analysts and investors that it expected net income to be greater than $10.35 per share, with over $0.45 per share attributed to the amortization of other intangible assets. Excluding this specific item, the company maintained its outlook for adjusted net income to exceed $10.80 per share. This guidance explicitly excluded potential transaction costs related to the pending acquisition of Cigna Corporation, any investment gains or losses, and other-than-temporary impairment losses on investments. These exclusions are consistent with the company's methodology for calculating adjusted net income, providing clarity on the underlying operational performance expected. The filing also included standard forward-looking statement disclaimers, highlighting various risks and uncertainties that could affect future results, including those related to the Cigna acquisition and regulatory environments.
Key Highlights
- 1Reaffirmed 2016 full-year net income guidance of greater than $10.35 per share.
- 2Projected adjusted net income for 2016 to be greater than $10.80 per share, excluding specific items.
- 3Guidance excludes transaction costs associated with the Cigna acquisition.
- 4Guidance excludes investment gains/losses and other-than-temporary impairment losses.
- 5Disclosure made during meetings with securities analysts and investors between March 16 and March 31, 2016.
- 6Included standard forward-looking statement disclaimers and risk factors.